Global Biopharmaceuticals Market

Biopharmaceuticals Market was valued at USD 154 Billion in 2017 and anticipated to grow at 13.3% CAGR during the forecast period.

Biopharmaceuticals Market Overview

Biopharmaceuticals are large molecules, used as medicinal drugs. Biopharmaceutical drugs are produced through complex biotechnological methods involving recombinant DNA techniques, hybridoma techniques, and purification processes. Biopharmaceutical production involves the use of living microorganisms, plants, or animal cells. These drugs help in prevention and treatment of various diseases such as cardiovascular disease, rheumatoid arthritis, psoriatic arthritis, psoriasis, anaemia arising from chemotherapy, chronic renal failure, cancer, and diabetes. Technological advancements in biopharmaceuticals have revolutionized the treatment of many serious and chronic illnesses, based on which the demand for biopharmaceutical products would greatly be boosted during the forecasted period. There are more than 300 approved biopharmaceutical drugs; the anti-inflammatory drug Humira is one of the best-selling drugs worldwide.

To have an edge over the competition by knowing the market dynamics and current trends of “Biopharmaceuticals Market”, request for Sample Report here

Biopharmaceuticals Market Overview

The global biopharmaceuticals market is forecast to witness a promising growth over the forecast period, owing to the accelerating ageing population and increasing investment in research and development. For example, the United Nations World Population Prospects 2019 report states that by 2050, one in six people will be above 65 years age, which is an increase from one in 11 in 2019. Factors which include the rising incidences of chronic diseases such as diabetes and cancer, growing adoption of biopharmaceuticals, and the increasing government emphasis to expand the biopharmaceuticals industry will propel the market growth over the forecast period. As per the Globocan 2020 report, nearly 19,292,789 new cancer cases were diagnosed worldwide, resulting in approximately 9,958,133 deaths. Moreover, expansion in the healthcare industry and the increasing consciousness about efficiency as well as the availability of biopharmaceuticals have augmented the Biopharmaceutical Market Share. In addition, the need to overcome the side effects of infectious surgical treatments has driven the biopharmaceuticals demand. However, the high prices of drugs, strict regulatory issues, and lack of proper infrastructure will restrain the Biopharmaceutical Market Size.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Top Market Players

Various notable players operating in the market, include Sanofi, F. Hoffmann-La Roche, AbbVie Inc, Pfizer, Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline, Eli Lilly and Company, AstraZeneca PLC, Bayer AG among others. Major players are focussing on R&D activities and strategic acquisition and merger activities to hold their leadership in this market. For instance, in 2018, Sanofi acquired Ablynx to expands growing rare blood disorders franchise with Ablynx’s late-stage investigational caplacizumab.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Key Developments: 

• • In 2021, Bristol Myers Squibb was granted an international exclusive license to develop, produce, and commercialize Rockefeller’s latest monoclonal antibody (“mAb”) duo treatment that neutralizes the SARS-CoV-2 virus COVID-19.
  • In 2021, Takeda Pharmaceutical entered into a partnership with Frazier Healthcare Partners to initiate a biopharmaceutical company named HilleVax to develop and market Takeda’s norovirus vaccine candidate, HIL-214 (previously TAK-214).
  • In 2020, Eli Lilly and Company acquired Dermira, a biopharmaceutical company. This acquisition was intended to expand the company’s biopharmaceutical portfolio with the addition of Dermira’s lebrikizumab, an IL-13 antibody that is used to treat of moderate-to-severe atopic dermatitis.

Segments covered in the Report:

The global biopharmaceuticals market has been segmented on the basis of product type, therapeutics application and key geographies. Based on product type, the market comprises of tissue intravascular cooling and intravascular warming. The research report “global biopharmaceuticals market” provides in-depth analysis of global biopharmaceuticals market based on product type, therapeutics application and major geographies for the forecasted period, from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global biopharmaceuticals market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For detailed scope of the “Biopharmaceuticals Market” report request a Sample Copy of the report

Market Segmentation

Global Biopharmaceuticals Market by Product Type

• •  Monoclonal antibody
  •  Interferon
  •  Insulin
  •  Growth factor
  •  Erythropoietin
  •  Vaccine
  •  Hormone
  • Others

Global Biopharmaceuticals Market by Therapeutic Application

• •  Oncology
  •  Blood disorder
  •  Metabolic disease
  •  Infectious disease
  •  Cardiovascular disease
  •  Neurological disease
  •  Immunology
  •  Others

Global Biopharmaceuticals Market by Region

• North America Silicone Gel Market (Option 1: As a part of the free 25% customization)

  • By Product Type
  • By Therapeutic Application
  • US Market All-Up
  • Canada Market All-Up

• Europe Silicone Gel Market (Option 2: As a part of the free 25% customization)

  • By Product Type
  • By Therapeutic Application
  • UK Market All-Up
  • Germany Market All-Up
  • France Market All-Up
  • Spain Market All-Up
  • Rest of Europe Market All-Up

• Asia-Pacific Silicone Gel Market (Option 3: As a part of the free 25% customization)

  • By Product Type
  • By Therapeutic Application
  • China Market All-Up
  • India Market All-Up
  • Japan Market All-Up
  • Rest of APAC Market All-Up

• RoW Silicone Gel Market (Option 4: As a part of the free 25% customization)

  • By Product Type
  • By Therapeutic Application
  • Brazil Market All-Up
  • South Africa Market All-Up
  • Saudi Arabia Market All-Up
  • UAE Market All-Up
  • Rest of world (remaining countries of the LAMEA region) Market All-Up

Leading market players

• Sanofi
• F. Hoffmann-La Roche
• AbbVie Inc.
• Pfizer, Inc.
• Merck & Co., Inc.
• Novartis AG
• Johnson & Johnson
• GlaxoSmithKline
• Eli Lilly and Company
• AstraZeneca PLC,
• Bayer AG

• *Other prominent players in the market which can be profiled as a part of customization:
• Amgen Inc.
• Gilead Sciences